Some OPAL libraries remain closed or are operating at reduced service levels. Materials from those libraries may not be requestable; requested items may take longer to arrive. Note that pickup procedures may differ between libraries. Please contact your library for new procedures, specific requests, or other assistance.
Your session will expire automatically in 0 seconds.
Biological weapons -- Russia. : Assessing the biological weapons threat : Russia and beyond : hearing before the Subcommittee on Europe, Eurasia, and Emerging Threats of the Committee on Foreign Affairs, House of Representatives, One Hundred Thirteenth Congress, second session, May 7, 2014.
Biological weapons -- Technological innovations. : Biodefense in the age of synthetic biology / Committee on Strategies for Identifying and Addressing Potential Biodefense Vulnerabilities Posed by Synthetic Biology, Board on Chemical Sciences and Technology, Board on Life Sciences, Division on Earth and Life Studies, the National Academies of Sciences, Engineering, Medicine.
Biologicals -- Effectiveness -- United States -- Measurement -- Standards. : The potential need for measurement standards to facilitate the research and development of biologic drugs : hearing before the Subcommittee on Technology and Innovation, Committee on Science and Technology, House of Representatives, One Hundred Eleventh Congress, first session, September 24, 2009.
Biologicals -- Purchasing -- Government policy -- United States. : Purchasing perspective : VA's prosthetics paradox : hearing before the Subcommittee on Oversight and Investigations of the Committee on Veterans' Affairs, U.S. House of Representatives, One Hundred Twelfth Congress, second session, Wednesday, May 30, 2012.
2013
1
Biologicals -- Research -- United States. : How can NIST better serve the needs of the biomedical research community in the 21st century? : hearing before the Subcommittee on Technology and Innovation, Committee on Science and Technology, House of Representatives, One Hundred Eleventh Congress, second session, February 24, 2010.
Biologicals -- Side effects. : Safety of biologics therapy : monoclonal antibodies, cytokines, fusion proteins, hormones, enzymes, coagulation proteins, vaccines, botulinum toxins / Brian A. Baldo.
2016
1
Biologicals -- Testing. : Guidance for industry : providing regulatory submissions to the Center for Biologics Evaluation and Research (CBER) in electronic format, lot release protocols.
